FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

Journal of Hepatology · 2009 · 1.7K citations

Hepatology, Liver Physiology, Cholestatic Liver Diseases +5

Diagnosis and Management of Primary Sclerosing Cholangitis

Roger W. Chapman, Johan Fevery, Anthony N. Kalloo et al. · Hepatology · 2009 · 1.2K citations

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

Annika Bergquist, Anders Ekbom, Rolf Olsson et al. · Journal of Hepatology · 2002 · 704 citations

Hepatology, Biliary Tract, Biliary Cancer +9

Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma

David Rea, Julie K. Heimbach, Charles B. Rosen et al. · Annals of Surgery · 2005 · 675 citations · Full text

Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin.

John L. Magnani, Zenon Steplewski, Hilary Koprowski et al. · PubMed · 1983 · 593 citations

Immunology, Gastroenterology, Pathology +21